BIOTRICITY INC. Interest Expense Nonoperating
BIOTRICITY INC. (BTCY) reported Interest Expense Nonoperating of $851.75 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-19.
Financial Statements › Expense Statement › Interest Expense
us-gaap:InterestExpenseNonoperating · last filed 2026-08-19
- BIOTRICITY INC. interest expense nonoperating for the quarter ending 2026-06-30 was $851.75K, a 0.18% increase year-over-year.
- BIOTRICITY INC. interest expense nonoperating for the quarter ending 2026-03-31 was $840.94K, a 5.70% decline year-over-year.
- BIOTRICITY INC. interest expense nonoperating for the quarter ending 2025-12-31 was $810.34K, a 4.61% decline year-over-year.
- BIOTRICITY INC. interest expense nonoperating for the quarter ending 2025-09-30 was $860.42K, a 14.41% increase year-over-year.
- BIOTRICITY INC. interest expense nonoperating for fiscal 2026 was $3.36M, a 3.06% increase from fiscal 2025.
- BIOTRICITY INC. interest expense nonoperating for fiscal 2025 was $3.26M, a 8.06% increase from fiscal 2024.
- BIOTRICITY INC. interest expense nonoperating for fiscal 2024 was $3.02M.
| Period end | Interest Expense Nonoperating 3 month | Interest Expense Nonoperating 6 month | Interest Expense Nonoperating 9 month | Interest Expense Nonoperating 12 month |
|---|---|---|---|---|
| 2026-06-30 | $851.75K 10-Q · filed 2026-08-19 | $1.69M derived: sum of 2 quarters · filed 2026-08-19 | $2.50M derived: sum of 3 quarters · filed 2026-08-19 | $3.36M derived: sum of 4 quarters · filed 2026-08-19 |
| 2026-03-31 | $840.94K derived: 10-K 12 month − 10-Q 9 month · filed 2026-07-14 | $1.65M derived: sum of 2 quarters · filed 2026-07-14 | $2.51M derived: sum of 3 quarters · filed 2026-07-14 | $3.36M 10-K · filed 2026-07-14 |
| 2025-12-31 | $810.34K 10-Q · filed 2026-02-11 | $1.67M derived: sum of 2 quarters · filed 2026-02-11 | $2.52M 10-Q · filed 2026-02-11 | $3.41M derived: sum of 4 quarters · filed 2026-08-19 |
| 2025-09-30 | $860.42K 10-Q · filed 2025-11-14 | $1.71M 10-Q · filed 2025-11-14 | $2.60M derived: sum of 3 quarters · filed 2026-08-19 | $3.45M derived: sum of 4 quarters · filed 2026-08-19 |
| 2025-06-30 | $850.25K 10-Q · filed 2026-08-19 | $1.74M derived: sum of 2 quarters · filed 2026-08-19 | $2.59M derived: sum of 3 quarters · filed 2026-08-19 | $3.34M derived: sum of 4 quarters · filed 2026-08-19 |
| 2025-03-31 | $891.75K derived: 10-K 12 month − 10-Q 9 month · filed 2026-07-14 | $1.74M derived: sum of 2 quarters · filed 2026-07-14 | $2.49M derived: sum of 3 quarters · filed 2026-07-14 | $3.26M 10-K · filed 2026-07-14 |
| 2024-12-31 | $849.54K 10-Q · filed 2026-02-11 | $1.60M derived: sum of 2 quarters · filed 2026-02-11 | $2.37M 10-Q · filed 2026-02-11 | |
| 2024-09-30 | $752.08K 10-Q · filed 2025-11-14 | $1.52M 10-Q · filed 2025-11-14 | ||
| 2024-06-30 | $768.67K 10-Q · filed 2025-08-14 | |||
| 2024-03-31 | $3.02M 10-K/A · filed 2025-07-18 |